TARDBP and amyotrophic lateral sclerosis: Indeed, the discovery in yeast that deletion of the ATXN2 (Ataxin-2) ortholog, PBP1, reduced TDP-43 toxicity, led to the recent exciting finding that reduction in ATXN2 levels dramatically lowers neurotoxicity in ALS mouse models [43].